The UK is facing a “collapse” of industry-initiated clinical trials in the UK, a report by the Association of the British Pharmaceutical Industry has warned.
The number of Phase III industry trials initiated in the UK fell by 48% between 2017 and 2021, from 269 trials to 140, found the report, published on 20 October
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?